Reports
Sale
Global Home Healthcare Market Share, Size, Analysis, Report: By Product: Therapeutic Product, Testing, Screening and Monitoring Products, Mobility Care Products; By Service: Skilled Nursing Services, Rehabilitation Therapy Services, Others; By Indication; By End User; Regional Analysis; Market Dynamics; Supplier Landscape; 2024-2032
Global Home Healthcare Market Outlook
The global home healthcare market size attained a value of USD 307 billion in 2023. The market is anticipated to grow at a CAGR of 8.26% during the forecast period of 2024-2032 to attain a value of USD 627.2 billion by 2032. The market growth is driven by the increased incidence of sleep apnea and other chronic disorders across the globe.
Global Home Healthcare Market Analysis
Home healthcare involves providing healthcare services to vulnerable individuals so that they can be treated in the comfort of their homes. It includes various services provided by skilled and unskilled healthcare professionals such as elder care services, and pregnancy care services, among others. Home healthcare may be short-term or long-term depending upon the needs of the patient and can involve the use of specialised tools and equipment.
The global home healthcare market requires a variety of equipment, depending upon the specific needs of the patient and the type of care. While certain products are used for monitoring purposes, others are used for treatment, and for the prevention of complications. Long-term usage equipment for the treatment of chronic conditions occupies a significant share of the market, with types of equipment comprising insulin delivery devices, inhalers, nebulizers, and sleep apnea therapeutic devices.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The newer technologies in this market have improved the communication flow between patients and healthcare providers, enabling better, faster, and more effective care. The increase in the prevalence of chronic conditions, growing awareness of lifestyle diseases, and the rise in elderly suffering from long-term health diseases will therefore increase the demand for home healthcare, proving favourable for market growth.
Increasing Number of Research and Development Activities in the Home Healthcare Market
Asthma is a major noncommunicable disease (NCD), affecting both children and adults, and is the most common chronic disease among children affecting more than 262 million people and causing 455,000 deaths. The increasing prevalence is calling for innovations and a sufficient supply-demand chain so that a maximum number of patients can avail of asthma therapeutics. To fill this crucial gap of unmet needs, researchers are trying to develop more effective and innovative inhalers for asthma patients. This initiative from the FDA and the practice by researchers is expected to propel the home healthcare market growth. For instance, the US Food and Drug Administration (FDA) has awarded a group of Australian researchers USD 687,000 to develop improved testing methods for dry powder inhalers. This project is expected to enable more effective development of inhalers, specifically generic inhaler devices. These developments are being performed to increase access to affordable inhalers for asthma patients in the United States and across the globe.
Investments Expected to Propel the Market Growth
The market is experiencing a significant trend toward developing monitoring equipment and technologies to diagnose and keep track of patient’s health activities with certain medical conditions. Medical disorders such as sleep apnea are among those that require continuous monitoring through specific monitoring devices. Huge amounts of funding are required to perform these developments that support the research and development procedure, further contributing to market growth. For instance, in December 2023, Aesyra, a medical device company developing oral appliance technologies to improve sleep, raised USD 3 million in seed financing to support the development and commercialization of the AesyBite line of products for accurate monitoring and treatment of sleep bruxism and sleep apnea.
Strategic Collaborations to Aid the Market Growth During the Forecast Period
The market for home healthcare is poised to grow significantly during the forecast period driven by strategic collaborations and partnerships between market key players. Such strategic moves by the companies are a major factor expected to bring innovation in the market development and propel the global home healthcare market growth.
For instance, In December 2023, Medtronic, a leading healthcare technology company, announced that it was expanding its partnership with Cosmo Intelligent Medical Devices, a subsidiary of Cosmo Pharmaceuticals. This partnership will strengthen Medtronic's position in the field of AI-integrated healthcare solutions and will mark a significant advancement in incorporating AI into endoscopic care. The collaboration will focus on innovative and scalable AI platforms like AI Access™, which is designed to host multiple third-party AI applications, allowing for faster innovation and streamlining of the AI development process across medical AI applications. This approach to healthcare represents a new and innovative way of thinking and will enable a broader spectrum of diagnostic tools and treatment options which may further come down to the home healthcare diagnostics.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Global Home Healthcare Market Segmentation
Market Breakup by Product
- Therapeutic Product
- Dialysis Equipment
- Wound Care Products
- IV Equipment
- Sleep Apnea Therapeutic Devices
- Insulin Delivery Devices
- Inhalers
- Others
- Testing, Screening, and Monitoring Products
- Blood Glucose Monitors
- Hearing Aids
- Blood Pressure Monitors
- Temperature Monitoring Device
- Ovulation & Pregnancy Test Kits
- Pulse Oximeters
- Drug and Alcohol test Kits
- Home Sleep Testing Devices
- Cholesterol Testing Products
- Home Hemoglobin A1C Test Kits
- Mobility Care Products
- Wheelchair
- Mobility Scooters
- Walkers and Rollators
- Crutches
- Others
Market Breakup by Service
- Skilled Nursing Services
- Rehabilitation Therapy Services
- Hospice and Palliative Care Services
- Unskilled Care Services
- Respiratory Therapy Services
- Infusion Therapy Services
- Pregnancy Care Services
Market Breakup by Indication
- Cancer
- Respiratory Disease
- Movement Disorders
- CVD & Hypertension
- Pregnancy
- Wound Care
- Diabetes
- Hearing Disorders
- Others
Market Breakup by End User
- Hospital and Clinics
- Ambulatory Surgical Centers
- Cancer Care Centers
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Global Home Healthcare Regional Analysis
The regional development and penetration of the home healthcare market depend heavily upon market maturity, awareness of the public, support from healthcare providers, and level of expense. North America heavily invested in the home healthcare sector and is a major leading region in the market for home healthcare. The large geriatric population, high volume of chronic diseases, and expensive hospital stays encourage spending on home healthcare. Due to the increased chronic conditions, regular monitoring of health is advised by healthcare professionals.
One of the common devices used regularly in home healthcare settings is a pulse oximeter, a device that oxygen saturation levels without using needles or fetching a blood sample. Innovation in such technologies is anticipated to boost the market demand during the forecast period in the region. For instance, In November 2023, GE HealthCare and Masimo announced a joint agreement to join Masimo Signal Extraction Technology® (SET®) pulse oximetry into GE HealthCare’s Portrait Mobile wireless and wearable patient monitoring solution. Portrait Mobile is an Internet of Medical Things (IoMT) platform, that provides an end-to-end experience for wearable continuous monitoring by using the latest cloud-native technology. By integrating Masimo SET®, clinicians will be able to leverage Masimo’s clinically proven Measure-through Motion and Low Perfusion™ oxygen saturation (SpO2) measurement technology to noninvasively detect and continuously monitor changes in patient status.
Global Home Healthcare Market: Competitor Landscape
In April 2023, DaVita and Medtronic launched their new venture Mozarc Medical, to develop new kidney care technologies focused on at-home treatments.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.
The major companies in the market are as follows:
- McKesson Medical Surgical Inc.
- Fresenius Medical Care
- Medline Industries, Inc.
- Medtronic Plc
- 3M Healthcare
- Baxter International Inc.
- B Braun Melsungen AG
- Arkray, Inc.
- F Hoffmann La Roche AG
- Becton, Dickinson and Company
- Acelity L.P.
- Hollister Inc.
- ConvaTech Group PLC
- Brookdale Senior Living, Inc.
- Care UK Limited
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Service |
|
| Breakup by Indication |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Market Overview
3.1 Global Home Healthcare Market Historical Value (2017-2023)
3.2 Global Home Healthcare Market Forecast Value (2024-2032)
4 Global Home Healthcare Market Landscape
4.1 Global Home Healthcare Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Home Healthcare Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Service
4.2.3 Analysis by Indications
5 Global Home Healthcare Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Home Healthcare Market Segmentation
6.1 Global Home Healthcare Market by Product
6.1.1 Market Overview
6.1.2 Therapeutic Product
6.1.2.1 Dialysis Equipment
6.1.2.2 Wound Care Products
6.1.2.3 IV Equipment
6.1.2.4 Sleep Apnea Therapeutic Devices
6.1.2.5 Insulin Delivery Devices
6.1.2.6 Inhalers
6.1.2.7 Others
6.1.3 Testing, Screening and Monitoring Products
6.1.3.1 Blood Glucose Monitors
6.1.3.2 Hearing Aids
6.1.3.3 Blood Pressure Monitors
6.1.3.4 Temperature Monitoring Device
6.1.3.5 Ovulation & Pregnancy Test Kits
6.1.3.6 Pulse Oximeters
6.1.3.7 Drug and Alcohol test Kits
6.1.3.8 Home Sleep Testing Devices
6.1.3.9 Cholesterol Testing Products
6.1.3.10 Home Hemoglobin A1C Test Kits
6.1.4 Mobility Care Products
6.1.4.1 Wheelchair
6.1.4.2 Mobility Scooters
6.1.4.3 Walkers and Rollators
6.1.4.4 Crutches
6.1.4.5 Others
6.2 Global Home Healthcare Market by Service
6.2.1 Market Overview
6.2.2 Skilled Nursing Services
6.2.3 Rehabilitation Therapy Services
6.2.4 Hospice and Palliative Care Services
6.2.5 Unskilled Care Services
6.2.6 Respiratory Therapy Services
6.2.7 Infusion Therapy Services
6.2.8 Pregnancy Care Services
6.3 Global Home Healthcare Market by Indication
6.3.1 Market Overview
6.3.2 Cancer
6.3.3 Respiratory Disease
6.3.4 Movement Disorders
6.3.5 CVD & Hypertension
6.3.6 Pregnancy
6.3.7 Wound Care
6.3.8 Diabetes
6.3.9 Hearing Disorders
6.3.10 Others
6.4 Global Home Healthcare Market by End User
6.4.1 Market Overview
6.4.2 Hospital & Clinics
6.4.3 Ambulatory Surgical Centers
6.4.4 Cancer Care Centers
6.4.5 Others
6.5 Global Home Healthcare Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Home Healthcare Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Home Healthcare Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Home Healthcare Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Others
10 Latin America Home Healthcare Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Home Healthcare Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Clinical Trials Analysis
14.1 Analysis by Trial Registration Year
14.2 Analysis by Trial Status
14.3 Analysis by Trial Phase
14.4 Analysis by Therapeutic Area
14.5 Analysis by Geography
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Regulatory Framework
17.1 Regulatory Overview
17.1.1 US FDA
17.1.2 EU EMA
17.1.3 INDIA CDSCO
17.1.4 JAPAN PMDA
17.1.5 Others
18 Supplier Landscape
18.1 McKesson Medical Surgical Inc.
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 Fresenius Medical Care
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 Medline Industries, Inc.
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 Medtronic Plc
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 3M Healthcare
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 Baxter International Inc.
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 B Braun Melsungen AG
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8 Arkray , Inc.
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 F Hoffmann La Roche AG
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
18.10 Becton, Dickinson And Company
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisitions
18.10.5 Certifications
18.11 Acelity L.P.
18.11.1 Financial Analysis
18.11.2 Product Portfolio
18.11.3 Demographic Reach and Achievements
18.11.4 Mergers and Acquisitions
18.11.5 Certifications
18.12 Hollister Inc.
18.12.1 Financial Analysis
18.12.2 Product Portfolio
18.12.3 Demographic Reach and Achievements
18.12.4 Mergers and Acquisitions
18.12.5 Certifications
18.13 ConvaTech Group PLC
18.13.1 Financial Analysis
18.13.2 Product Portfolio
18.13.3 Demographic Reach and Achievements
18.13.4 Mergers and Acquisitions
18.13.5 Certifications
18.14 Brookdale Senior Living, Inc.
18.14.1 Financial Analysis
18.14.2 Product Portfolio
18.14.3 Demographic Reach and Achievements
18.14.4 Mergers and Acquisitions
18.14.5 Certifications
18.15 Care UK limited
18.15.1 Financial Analysis
18.15.2 Product Portfolio
18.15.3 Demographic Reach and Achievements
18.15.4 Mergers and Acquisitions
18.15.5 Certifications
19 Global Home Healthcare Market - Distribution Model (Additional Insight)
19.1 Overview
19.2 Potential Distributors
19.3 Key Parameters for Distribution Partner Assessment
20 Key Opinion Leaders (KOL) Insights (Additional Insight)
21 Company Competitiveness Analysis (Additional Insight)
21.1 Very Small Companies
21.2 Small Companies
21.3 Mid-Sized Companies
21.4 Large Companies
21.5 Very Large Companies
22 Payment Methods (Additional Insight)
22.1 Government Funded
22.2 Private Insurance
22.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 307 billion in 2023 driven by increasing incidence of chronic disorders across the globe.
The market is anticipated to grow at a CAGR of 8.26% during the forecast period of 2024-2032, likely to reach a market value of USD 627.2 billion by 2032.
The market is expected to be aided by factors such as increased investments, collaborations and acquisitions, research and development, and innovative product launches.
The increased trend toward collaboration between market players to start new ventures is greatly influencing market growth.
Various types of products include therapeutic products, testing, screening, and monitoring products, and mobility care products.
Home healthcare services include skilled nursing services, rehabilitation therapy services, hospice and palliative care services, unskilled care services, respiratory therapy services, infusion therapy services, and pregnancy care services.
Home healthcare is indicated for cancer, respiratory disease, movement disorders, CVD and hypertension, pregnancy, wound care, diabetes, hearing disorders, and others.
End users in the market are hospitals, clinics, ambulatory surgical centers, cancer care centers, and others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Key players involved in the market are McKesson Medical Surgical Inc., Fresenius Medical Care, Medline Industries, Inc., Medtronic Plc, 3M Healthcare, Baxter International Inc., B Braun Melsungen AG, Arkray, Inc., F Hoffmann La Roche AG, Becton, Dickinson and Company, Acelity L.P., Hollister Inc., ConvaTech Group PLC, Brookdale Senior Living, Inc., Care UK Limited.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER